Liver Disease

The assay builds on the clinical potential of liquid biopsy platforms and could expand this technology’s utility to detect conditions besides cancer

McMaster-led study shows hidden fat contributes to artery damage, regardless of body weight

The RNA-based test enables single-visit testing for HCV in about an hour, streamlining access to treatment

The FDA granted the approval of Rezdiffra to Madrigal Pharmaceuticals

New algorithms developed by clinicians and data scientists could help personalize treatment

MASH is expected to surpass hepatitis C as the main cause of liver transplantation in the US 

The 3D microchip works as a patient-specific drug-testing platform for a rare liver cancer

The gut microbiome is responsible for producing many volatile chemicals found in exhaled breath

Some 70–90 percent of patients with hepatocellular carcinoma experience cancer recurrence after curative treatment